Literature DB >> 1379093

Effects of chronic amitriptyline administration on saliva from the parotid and submandibular glands of the rat.

J H Yu1.   

Abstract

The effect of prolonged treatment with amitriptyline on the secretory activity of rat salivary glands evoked by parasympathetic nerve stimulation and isoprenaline administration has been studied. Low doses of amitriptyline (10 mg/kg per day for 2 or 4 weeks), did not significantly affect salivary flow evoked by either parasympathetic nerve or isoprenaline stimulation. Higher doses of amitriptyline (50 mg/kg/day for 2 or 4 weeks) however, markedly decreased parasympathetic-evoked salivary secretion (flow and volume) from both parotid and submandibular glands, while isoprenaline-evoked secretions were unaffected. Sodium, potassium, and calcium concentrations of nerve-elicited or isoprenaline-evoked saliva were not significantly altered by amitriptyline treatment. Protein concentration and amylase activity of nerve-elicited parotid saliva were, however, greatly increased by chronic amitriptyline administration. Possible mechanisms for drug-induced increase in nerve-elicited salivary protein concentration include changes in cholinergic receptor binding, release of neuropeptides and variations in phosphatidylinositol turnover, which need further study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379093     DOI: 10.1007/bf01824205

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  21 in total

1.  Tricyclic antidepressants, mianserin, and ouabain stimulate inositol phosphate formation in vitro in rat cortical slices.

Authors:  N N Osborne
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

Review 2.  Phosphatidylinositol turnover in receptor mechanism and signal transduction.

Authors:  K Hirasawa; Y Nishizuka
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

Review 3.  Receptors and phosphoinositide-generated second messengers.

Authors:  L E Hokin
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 4.  Cell signalling through phospholipid metabolism.

Authors:  M J Berridge
Journal:  J Cell Sci Suppl       Date:  1986

5.  Subjective reports of xerostomia and objective measures of salivary gland performance.

Authors:  P C Fox; K A Busch; B J Baum
Journal:  J Am Dent Assoc       Date:  1987-10       Impact factor: 3.634

6.  Oral conditions in patients receiving long-term treatment with cyclic antidepressant drugs.

Authors:  J Rundegren; J van Dijken; H Mörnstad; L von Knorring
Journal:  Swed Dent J       Date:  1985

7.  AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITY.

Authors:  L Maître; P Moser; P A Baumann; P C Waldmeier
Journal:  Acta Psychiatr Scand       Date:  1980-03       Impact factor: 6.392

8.  Therapy-induced dysfunction of salivary glands: implications for oral health.

Authors:  B J Baum; L Bodner; P C Fox; K T Izutsu; P A Pizzo; W E Wright
Journal:  Spec Care Dentist       Date:  1985 Nov-Dec

9.  Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels.

Authors:  L Clemmesen; P L Mikkelsen; H Lund; T G Bolwig; O J Rafaelsen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Saliva secretion rate and saliva composition as a model to determine the effect of antidepressant drugs on cholinergic and noradrenergic transmission.

Authors:  L von Knorring; H Mörnstad
Journal:  Neuropsychobiology       Date:  1986       Impact factor: 2.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.